KIMS.NS Stock Analysis
KI
Avoid
Based on Eyestock quantitative analysis, KIMS.NS`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Krishna Institute of Medical Sciences Ltd. engages in the provision of healthcare services. The company is headquartered in Secunderabad, Telangana and currently employs 10,000 full-time employees. The company went IPO on 2021-06-28. The Company’s departments include accident, Alzheimer center, andrology and infertility center, pediatric obesity, pediatric oncology, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal center, pediatric surgical center, female urology center, fertility center, gastrointestinal oncology, general surgery, heart wellness center and hepatobiliary surgery center. Its technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, EBUS, Spy Glass, Mako Robotic for Knee Replacement, and Impella. The Company’s institutes include the institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, and Institute of Neuro Sciences.